Results 151 to 160 of about 183,878 (231)

Preventing secondary primary malignancies (SPMs) in CAR-T cell therapy through site-specific transgene integration into genomic safe harbors (GSHs). [PDF]

J Transl Med
Safarzadeh Kozani P, Safarzadeh Kozani P.   +1 more
europepmc   +1 more source

High-efficiency homology-directed insertion into the genome using the engineered homing endonuclease ARCUS. [PDF]

Nucleic Acids Res
Resly LC, Tubbs AL, Vogel AJ, Hux JA, MacDonald IA, Harris J, Mischler A, Tomberlin GH, Evans KS, Thompson R, Sunman J, Lape J, Smith JJ, Martin AJ.   +13 more
europepmc   +1 more source

Séminaire TRACS: Culture matérielle

Transatlantic Cultures, 2022
openaire   +1 more source

c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors. [PDF]

Cell Rep Med
Balke-Want H, Keerthi V, Del Carmen Arenas M, Chen Y, Malipatlolla M, Klysz DD, Xu P, Ho K, Asano K, Stahl D, Huang J, Retherford A, Patel S, Fowler C, Maas L, Gkitsas-Long N, Jiang Q, Liu X, Ullrich R, George J, Heitzeneder S, Tunuguntla R, Sage J, Sotillo E, Mackall CL, Feldman SA.   +25 more
europepmc   +1 more source

Orthogonal CRISPR systems for targeted integration and multiplex base editing enable nonviral engineering of allogeneic CAR-T cells. [PDF]

Mol Ther
Mikkelsen NS, Ravendran S, Broksø AD, Skjelbostad SF, Pedersen MG, Fang H, Terkelsen T, Thomsen MK, Bak RO.   +8 more
europepmc   +1 more source

Keeping TRACs on government [PDF]

Index on Censorship, 1991
openaire   +1 more source

The assembly of a hybrid type IV secretion system by a Crohn's disease-associated Escherichia coli strain. [PDF]

Nat Commun
Wong J, Refaat A, Villacampa-Teixeira P, Patkowski JB, Lapa N, Ortiz J, Dzierlega K, Roberts B, Tollenaar S, Croxen M, Thiesen A, Kao D, Willing B, Clemente-Casares X, Costa TRD, Elhenawy W.   +15 more
europepmc   +1 more source

Multiplex engineering and multifunction T cells for precise and effective immunotherapies. [PDF]

Front Immunol
Jafarzadeh L, Smaani A, Delisle JS.
europepmc   +1 more source

CRISPR tools for T cells: targeting the genome, epigenome, and transcriptome. [PDF]

Trends Cancer
Wachsmann TLA, Qi LS.
europepmc   +1 more source

Harnessing the potential of gene editing technology for CAR-T cell therapy of solid tumors. [PDF]

Inflamm Regen
Khodabandehloo E, Rayati M, Ahmadi E, Naghdibadi M, Moradi V, Ahmadbeigi N.   +5 more
europepmc   +1 more source